During the past decade, Garden State Urology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Garden State Urology" #1 sponsor was "Eli Lilly and Company" with 1 trials, followed by "Hoffmann-La Roche" with 1 trials sponsored, "Integra LifeSciences Corporation" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Garden State Urology" #1 collaborator was "Fox Chase Cancer Center" with 1 trials as a collaborator, "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator, "Rutgers Cancer Institute of New Jersey" with 1 trials as a collaborator and "Sarah Cannon Development Innovations" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Garden State Urology" are "Prostatic Neoplasms" (2 trials), "Bladder Cancer" (1 trials), "Pelvic Organ Prolapse" (1 trials), "Prostate Cancer" (1 trials) and "Prostate Cancer Metastatic" (1 trials). Many other conditions were trialed in "Garden State Urology" in a lesser frequency.

Most popular intervention types in "Garden State Urology" are "Drug" (4 trials), "Device" (2 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Androgen Deprivation Therapy (ADT)" (1 trials), "Apalutamide" (1 trials), "Atezolizumab" (1 trials) and "Enzalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Garden State Urology" are 3 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Garden State Urology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Garden State Urology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Garden State Urology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".